Steven O'Day - Jan 5, 2023 Form 4 Insider Report for AGENUS INC (AGEN)

Signature
/s/ Christine Klaskin, as attorney-in-fact for Steven O'Day
Stock symbol
AGEN
Transactions as of
Jan 5, 2023
Transactions value $
$267,983
Form type
4
Date filed
1/9/2023, 04:42 PM
Previous filing
Feb 4, 2022
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $268K +109K +67.1% $2.45 272K Jan 5, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +200K $0.00 200K Jan 5, 2023 Common Stock 200K $2.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.
F2 $2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.
F3 Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.